2016
DOI: 10.1053/j.jvca.2015.10.017
|View full text |Cite
|
Sign up to set email alerts
|

A Case of Fatal Bleeding Following Emergency Surgery on an Ascending Aorta Intramural Hematoma in a Patient Taking Dabigatran

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
9
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 16 publications
0
9
0
Order By: Relevance
“…Because emergency surgery in patients under dabigatran treatment has been associated with severe or even fatal bleeding, it is recommended that DOACs be discontinued at least 48 h before cardiac surgery. [78][79][80] DOACs may be bridged by heparins in patients with acute thrombotic events o 4 weeks. The half-life of DOACs may be prolonged in case of impaired renal function (Table 3).…”
Section: Vitamin K Antagonistsmentioning
confidence: 99%
“…Because emergency surgery in patients under dabigatran treatment has been associated with severe or even fatal bleeding, it is recommended that DOACs be discontinued at least 48 h before cardiac surgery. [78][79][80] DOACs may be bridged by heparins in patients with acute thrombotic events o 4 weeks. The half-life of DOACs may be prolonged in case of impaired renal function (Table 3).…”
Section: Vitamin K Antagonistsmentioning
confidence: 99%
“…Yeoh et al reported lung injury from the use of a suction catheter via the DLT and stated that the suction tip penetrated into the normal lung tissue. 1 To the best of our knowledge, our report is the first case of pulmonary hemorrhage resulting from suction catheter placement during VATS. Lung collapse is important for adequate surgical exposure during VATS.…”
mentioning
confidence: 73%
“…5 The median age of these patients was 76 years old, similar to our patient and others (76 to 82 years old). [1][2][3] Hemostasis during the procedure was clinically judged to be adequate in 92% of cases, but with a high mortality rate of 23.1%, mainly due to cardiovascular causes.…”
Section: Idarucizumab For Dabigatran Reversal In Emergency Type-a Aormentioning
confidence: 99%
See 1 more Smart Citation
“…Following platelets and fibrinogen concentrate administration, clot strength recovered, but time to clot formation was still prolonged and even the subsequent administration of rFVIIa failed to normalize CT at EXTEM. 51…”
Section: Ex Vivo Studiesmentioning
confidence: 99%